Close
Show

Clinical Trials

World Pharma Today clinical Trials covers all updates & latest in clinical trials news, Pharma clinical trial company news, clinical trials technology…

Novartis study shows drug Afinitor plus hormonal therapy delays disease progression in advanced...


A new study shows that the addition of everolimus (Afinitor® tablets) to the hormonal therapy...

Phase III study showed Rituxan/MabThera decreased the risk of needing later treatment with chemotherapy...


Roche announced positive data from a Phase III study of Rituxan/MabThera (rituximab) in patients with...

QR Pharma receives FDA clearance to conduct clinical trials with its second novel Alzheimer...


  QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), announced...

Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies


Bayer HealthCare and Regeneron Pharmaceuticals, Inc. announced that in two parallel Phase 3 studies in...

Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl


Abbott Park, Illinois-Reata Pharmaceuticals and Abbott today announced data from a Phase 2b study which...

Novartis discontinues ASA404 clinical trial program and shifts focus to other cancer compounds in...


Novartis announced that the clinical trial program for the investigational cancer treatment ASA404 (vadimezan) will...

Genentech announced the result of Phase II clinical trail of RG7204


Genentech, Inc., a member of the Roche Group announced results from a Phase II clinical...

Sanofi Pasteur’s Dengue Vaccine in Final Stage of Clinical Development


Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that its dengue vaccine is in...

Roche reports promising Phase II results with new targeted approach in advanced melanoma


Roche announced results from a Phase II clinical study of RG7204 PLX4032), an investigational first-in-class...

Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML


Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine)...